Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 102, Issue 5, Pages 1650-1660Publisher
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.23510
Keywords
biocompatibility; alkoxylphenacyl; polycarbonates; photoresponsive; implants; toxicity
Funding
- NEOMED
- University of Akron
Ask authors/readers for more resources
Potential toxicities of chromophoric or polymeric units of most photoresponsive delivery systems have impacted clinical relevance. Herein, we evaluated the biocompatibility and tolerability of alkoxylphenacyl-based polycarbonates (APPs) as a new class of photoresponsive polymers. The polymers were applied as homopolymer or copolymers of polyethylene glycol (10%, w/w) or polycaprolactone (10%, w/w). APP polymers were comparable to poly(lactic-co-glycolic acid) (PLGA) based on cytotoxicity, macrophage activation, and blood compatibility. Data from biodistribution studies in BALB/c mice showed preferential accumulation in kidney and liver. Meanwhile, potential application of APP polymers as immediate or sustained (implants) drug delivery systems indicated that liver and kidney functions were not distorted. Also, plasma levels of tumor necrosis factor-alpha and interleukin-6 were comparable to PLGA-treated mice (p > 0.05). A histological analysis of liver and kidney sections showed no detectable damage for APP polymers. The overall data strongly supported potential consideration of APP polymers as photoresponsive delivery systems especially as implantable or tissue-mimicking photopatterned biomaterials. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:16501660, 2013
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available